The findings were similar for CA 125 and HE4, as their concentrations were also the highest among patients diagnosed with sarcomas and carcinomas (CA 125, 43.15 U/mL and 26.55, respectively; HE4, 90.3 pmol/L, and 77.35 pmol/L, respectively). Here, WFDC2 is linked to sarcoma.